Smith & Nephew (SNNUF) Change in Inventory (2023 - 2024)

Smith & Nephew (SNNUF) reported Change in Inventory of -$119.0 million for Q4 2024, up 41.67% on a YoY basis from -$84.0 million in Q1 2024, and up 41.67% quarter-over-quarter from -$204.0 million in Q4 2023.

Smith & Nephew (SNNUF) Change in Inventory (2023 - 2024) Analysis & Trends

Smith & Nephew has reported Change in Inventory for 2 years, with the latest figure at -$119.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 420.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 127.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 1.60 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 171.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 65.20 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -38.50 Mn
10 Smith & Nephew - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -119.00 Mn
Dec 31, 2024 -119.00 Mn
Dec 31, 2023 -204.00 Mn
Dec 31, 2023 -204.00 Mn